Hera Biotech’s Post

Today, on the International Day of Women and Girls in Science, let's address the vital need for more female representation in the field of medicine, particularly in light of shocking revelations like period products were tested with actual blood for the first time ever in 2023 (Yes, you read that right, 2023!) >> https://lnkd.in/dMJCpDUX This highlights just how far we still need to go when it comes to women's health, and why we need to have more Women and Girls in Science! At MindUP - The Digital Health Incubator, we're proud to support innovative companies like Nevia bio and DermAb.io, who are revolutionizing women's healthcare >> https://lnkd.in/daKzyf2 Nevia bio focuses on early disease detection through vaginal secretions analysis, empowering women to take control of their health. DermAb.io is developing a smarter platform for precision medicine in chronic & autoimmune diseases, which overwhelmingly afflict women. Let's champion female-led innovation and pave the way for a healthier future for all women! Take a look on what Miriam Oron Ph.D. and Meital Portugal, PhD had to say >> #WomenInHealth #HealthcareInnovation Maura Rosenfeld, Dan Shwarzman, Zvika Shinar, Dalia Mor, Judith Hammerschlag Grynbaum, Inbal Zafir-Lavie, Zohar Shnaider, Shlomit Yehudai-Reshef, PhD

🌟 Introducing ViVBioTech – Pioneering the Future of Women's Healthcare 🌟 Welcome to ViVBioTech! As leaders in biotechnological innovation, we are dedicated to redefining women's healthcare. Founded with the principle that research should inclusively reflect the diversity of human physiology, our mission is clear: to revolutionize healthcare by developing advanced biotechnological models tailored specifically for female biology. We are tackling global health challenges faced by women with cutting-edge technologies and rigorous scientific research. Our focus is on creating sex-specific models. These initiatives are part of our broader commitment to fill significant gaps left by traditional research methodologies and pave the way for more effective, personalized treatments. At ViVBioTech, we envision a world where the complexities of female biology are central to healthcare solutions. By specializing in tissue engineering and organ-on-a-chip technology, we aim to offer personalized and equitable healthcare solutions that cater uniquely to women's needs. Join us on our journey to transform women's healthcare. Together, we can foster a healthier, more equitable world for all. Learn more about our groundbreaking work and join the conversation on how we're shaping the future of healthcare at https://lnkd.in/dzDww-iB.

Following up the women's health equity discussion is the “Charting the Path for Successful Commercialization Strategies” panel session moderated by Lisa Carmel, EVP Global Strategic Partnerships at Veranex, one of our generous Platinum Sponsors of #InnovationDublin24:   ●     Virginia Giddings, Vice President Exploration, Edwards Lifesciences ●     Toon Overbeeke, CEO, Vitestro ●     Gerard Hascoët, Sofinnova Partners ●     Kip Roberts, VP, Business Development & Strategy Neuroscience, Medtronic Key takeaways: "If you want to get the attention of the strategics, instead of showing them a graph of revenues shooting up north of $1 billion, show a de-risking curve. " Within your large TAM estimate, you need to understand the patient population that aligns with your therapy the best in terms of their need and your solution. "TAVR is a disruptive patient treatment and an almost $6 billion business in 2023, but let’s not forget that it’s taken us 20 years to get here." Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

Closing gaps in healthcare and in the medtech industry takes unwavering determination and commitment. While we appreciate and support minority medtech trailblazers every day, MedTech Impact Partners wants to celebrate this Juneteenth by recognizing inspirational founders and their companies. Thank you Trivia Frazier, PhD, MBA, Charles Cathlin, Tshaka Cunningham and Patrick Hines for your ongoing work to create equitable access and treatment for all patients. If you're reading this post and not familiar with their work, we encourage you to take a few minutes to learn more and share with your network. Polaris Genomics Functional Fluidics #obtalasciences #juneteenth #healthcareequity #medtechinnovators #medtechcolor #polarisgenomics #functionalfluidics #medtech #closethegap #happyjuneteenth

FemTech start-ups share in $110m Sprint for Women's Health Ovarian health biotech Celmatix and HPV-treatment innovator Daré Bioscience, Inc. will share in $110m as part of the Advanced Research Projects Agency for Health (ARPA-H) 'Sprint for Women's Health.' A total of 23 organisations from around the world will receive a slice of $110m in funding to address critical unmet challenges in women’s health, champion transformative innovations and tackle health conditions that uniquely or disproportionately affect women. HHS Secretary Xavier Becerra said: “In order to improve women’s health, we need to pursue and invest in research focused on advancements for women. This is especially true where we know far too little about how to prevent and treat a range of conditions that affect women across their lifespan.” “The Biden-Harris Administration continues to change how health research is pursued and utilized. The groups being recognized today have picked up that challenge and are doing work that is groundbreaking and lifesaving.” Sabrina Johnson Piraye Beim ➡ Full story including all the winners: https://lnkd.in/eC-xYGVk

After a successful Women in Advanced Therapies Global, What's next for Phacilitate? - 10th September (Estoril, Portugal) Women in Advanced Therapies Congress (Europe) Advanced Therapies Investment Summit (Europe) - 10-11-12th September (Estoril, Portugal) Advanced Therapies Europe - 20-21-22-23rd January 2025 (Dallas, Tx) Advanced Therapies Week #Phacilitate #AdvancedTherapiesWeek #AdvancedTherapiesEurope #ATW25 #ATE24 #celltherapy #genetherapy #cellandgenetherapies #ATMPs #AdvancedTherapies

Women's health is massively underfunded. And NOW is the time to address this urgent gap! ⏰ It was a privilege to be part of the FemTechnology Summit held last summer at Roche where we co-created concrete solutions to pressing issues in women’s health with all ecosystem players - including start-up founders, patients, researchers, students, VCs, healthcare providers, hospitals, and large pharma. 🚀 💫 I'm proud that we’re translating ideas into tangible actions that can change the way healthcare is delivered to women globally. 🌍 One of the most important aspects is about unlocking funding for new innovations in #womenshealth! 💸 👩🏻🦱 💸 👩🏽🦱 💸 👵🏼 💸 👩🏻🦰 The team at Catenion has developed a paper outlining the ways to address the need for Financing Innovation in Women’s Health. 🙌 This paper proposes a comprehensive approach, including policy-making, public investment, and collaborative efforts, inspired by successful models in other fields such as orphan drug development. 👏 ---> I highly encourage you to read this paper here: http://bit.ly/3H46LMn 🚨 and to take action to help drive change to ensure equity of care for women. 🙏 I am committed to being part of driving this change, can we count on your commitment, too? 💪  #MyStoryforChange #XProject #womenshealth #innovation

Looking forward to this panel tomorrow! Dorothea Ledergerber Vasiliki Kalodimou Jessica Cordes We'll touch on the major challenges of operating in Europe, including Regulatory, Technical, and market/access, what works and what doesn't, and how we can improve patient access to ATMPs in Europe Women in Advanced Therapies #WiATGlobal #WomeninAdvancedTherapies #AdvancedTherapies #CellTherapies #GeneTherapies

As women’s healthcare becomes an increasing priority, FemTech is rising to meet the challenge as it matches capital and talent with unmet needs. In a short period of time, FemTech has already demonstrated impressive early wins. An even greater disruption could be ahead. It's time to join the femtech revolution. #femtech #investoropportunity #fundinground #womenshealth #menopauseapp #moxiemenopause https://lnkd.in/dE9TPtCY

"Collaboration" was a key theme during day 4 of the 2024 Women of Color in Pharma (WOCIP) Cluster Meetings. #Collaboration with the right people, such as community healthcare providers and patient advocacy groups, is crucial. By understanding the specific challenges faced by marginalized communities, companies can more purposely select and leverage technology effectively to design solutions that truly address health equity concerns. To bridge the gap between pharmaceutical companies' resource allocation and the growing need for health equity initiatives, companies can use #technology as a tool to address these disparities and need to adopt a "purposeful #vision" approach. This means clearly defining the target audience, desired impact, and timelines before starting any project. Quotes from LaToya Coffey, PhD, Charlotte Jones-Burton, MD, MS, and Rizwana Seeham Key Takeaways from Clarkston's Brandon Miller, Erica Parks Murray, and LaToya Lee Jones Learn more about the importance of #equitable clinical trials here: https://lnkd.in/eHi-YwET